# A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection

> **NCT06008860** · PHASE4 · RECRUITING · sponsor: **University of Chicago** · enrollment: 280 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Experimental: Primary Cohort
- **OTHER:** Placebo Comparator: Primary Cohort - Placebo

## Key facts

- **NCT ID:** NCT06008860
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2025-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06008860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06008860, "A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06008860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*